ArticleJournal of leukocyte biology2026
Single-cell and spatial transcriptomics define eosinophil heterogeneity during influenza A virus-induced exacerbation of fungal allergic asthma in C57BL/6 mice.
Article in Journal of leukocyte biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Although eosinophils (EOS) are accepted as transcriptionally heterogeneous in asthma, how allergic inflammation shapes EOS states during influenza A virus (IAV) infection remains undefined. We integrated high-resolution single-cell RNA sequencing, spatial transcriptomics, quantitative immunofluorescence imaging, and cell-cell communication analyses to profile murine lungs across naïve, asthma, influenza (flu), and co-morbid asthma and flu (asthma + flu) conditions. We identified 3 related EOS transcriptional states distributed along a disease-associated continuum. EOS in the flu-only condition preferentially expressed canonical antiviral and interferon-stimulated genes, including Isg15, Gbp2, and Samhd1, whereas asthma + flu EOS had attenuated induction of these programs together with enrichment of genes associated with chemotaxis, adhesion, inflammatory regulation, and metabolic remodeling. Asthma + flu EOS were also enriched for a human asthma-associated high EOS gene signature. A progressive shift in EOS from antigen-presenting programs toward chemotactic and tissue remodeling-associated states, as identified by pseudotime analysis, may imply a changing functional emphasis rather than sustained canonical antiviral activation. Spatial profiling confirmed condition-dependent EOS abundance, increased EOS Alox15 expression in allergic conditions, and disease-specific cellular neighborhoods. Cross-platform analyses identified recurrent predicted interactions between EOS and a distinct Alox15+ alveolar macrophage population. Mast cells adopted infection-specific interleukin-1 and leukocyte-activation transcriptional programs without major compositional changes. Collectively, these findings demonstrate that the type 2 microenvironment reshapes both the transcriptional state and spatial organization of lung EOS during IAV infection, providing an integrated framework for understanding EOS heterogeneity and cellular coordination in the allergic lungs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.